<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Parathyroid - Secondary &amp; Tertiary Hyperparathyroidism (Part 2)</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Parathyroid - Secondary &amp; Tertiary Hyperparathyroidism (Part 2)</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                7 Questions | 7 Total Marks | 17 min Duration | ~145.71 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 7 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 17 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 7</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Parathyroid - Secondary &amp; Tertiary Hyperparathyroidism (Part 2) - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 7</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 7 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A patient, who is a known case of secondary Hyperparathyroidism, came to the surgery OPD with the following lesion. He was immediately started on medical management and then taken for urgent surgery. What is the most suitable surgical option for this patient?", "options": [{"label": "A", "text": "Subtotal Parathyroidectomy", "correct": false}, {"label": "B", "text": "Total Parathyroidectomy without Thymectomy", "correct": false}, {"label": "C", "text": "Total Parathyroidectomy with Transcervical Thymectomy", "correct": true}, {"label": "D", "text": "Subtotal Parathyroidectomy with Transcervical Thymectomy", "correct": false}], "correct_answer": "C. Total Parathyroidectomy with Transcervical Thymectomy", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683766898358-QTDS025001IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Total Parathyroidectomy with Transcervical Thymectomy The image given is that of Calciphylaxis or Calcific Uremic Arteriolopathy. It is characterized by painful violaceous skin lesions with associated ulceration, ischemia, necrosis, and eschar formation. An urgent parathyroidectomy has been shown to decrease pain, improve wound healing and reduce the risk of amputation in these patients. It has also been associated with an increase in median survival. Because of the high mortality associated with calciphylaxis (87%) and the potential for progression after subtotal parathyroidectomy , total parathyroidectomy with trans-cervical thymectomy is the preferred surgical option.</p>\n<p><strong>Highyeild:</strong></p><p>Calciphylaxis causes painful skin lesions with ulceration, necrosis, and eschar formation. Patients with calciphylaxis may develop non-healing wounds with skin necrosis and risk complications such as gangrene, sepsis, and death. Mortality rates are high, ranging from 50% to 80%. The causes : medically-refractory hyperphosphatemia, a high calcium-phosphate product, high PTH levels, use of warfarin, protein C and protein S deficiency, and other causes of thrombophilia. A diagnosis is made in patients with chronic kidney disease and secondary HPT who have painful, violaceous, tender skin lesions and a skin biopsy showing vascular and extravascular calcifications without vasculitis.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A . Subtotal parathyroidectomy is not done, as progression after it can be fatal. Option: B . Total parathyroidectomy with autologous graft is done in cases of secondary HPT . But it is paired with thymectomy in all cases. Option: D. Subtotal parathyroidectomy is not done, as progression after it can be fatal.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 52-year-old patient, with chronic renal disease, hypocalcemia, with elevated PTH. Patient has a high serum phosphate and a low vitamin D level. The definitive treatment for this condition is:", "options": [{"label": "A", "text": "Subtotal Parathyroidectomy", "correct": false}, {"label": "B", "text": "Calcimimetic Drug, Cinacalcet, based therapy", "correct": false}, {"label": "C", "text": "Total Parathyroidectomy", "correct": false}, {"label": "D", "text": "Renal Transplant", "correct": true}], "correct_answer": "D. Renal Transplant", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Renal Transplant Treatment of Secondary Hyperparathyroidism has changed radically with the introduction of Calcimimetic drugs, such as cinacalcet. Calcimimetics alter the set point of the CaSR, thereby reducing the constant stimulation of the parathyroid glands and lowering the PTH level. The case scenario described is that of secondary hyperparathyroidism. Renal transplantation remains the only definite treatment for secondary hyperparathyroidism . Other treatments act as a bridge to provide symptom relief. Calcium Supplementation Vitamin D Supplementation Phosphate Binder Calcimimetic Drug Surgical intervention ( Parathyroidectomy )</p>\n<p><strong>Highyeild:</strong></p><p>Renal transplantation is the only definitive treatment for secondary hyperparathyroidism. Standard management includes calcium and vitamin D replacement, phosphate binders, and reduction of phosphate levels. Calcimimetic drugs like cinacalcet can lower PTH levels by altering the calcium-sensing receptor set point. Surgery options include subtotal parathyroidectomy and total parathyroidectomy with or without autograft.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A . Subtotal parathyroidectomy is where three and a half parathyroid glands are excised, with the remnant being marked with a non-absorbable stitch to facilitate identification in the event of recurrent disease. Option: B. Total parathyroidectomy with a forearm autograft involves removal of all parathyroid tissue in the neck, with reimplantation of a small amount of morcellated tissue within a pocket formed in the brachioradialis muscle. Option: C. Renal transplantation remains the only definite treatment for secondary hyperparathyroidism.</p>\n<p><strong>Extraedge:</strong></p><p>Cryopreservation should be done in significant hypocalcemia. Subtotal parathyroidectomy and total parathyroidectomy are the most widely accepted.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient was found to have hypocalcemia with elevated PTH and high serum phosphate levels. All of the following are the PRIMARY cause for this condition, EXCEPT:", "options": [{"label": "A", "text": "Parathyroid Adenoma", "correct": true}, {"label": "B", "text": "Chronic Renal Failure", "correct": false}, {"label": "C", "text": "Intestinal Malabsorption", "correct": false}, {"label": "D", "text": "Vitamin D3 Deficiency", "correct": false}], "correct_answer": "A. Parathyroid Adenoma", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Parathyroid Adenoma Parathyroid Adenoma is a cause of Primary Hyperparathyroidism, which generally has HIGH serum Calcium, HIGH PTH, and LOW serum Phosphate levels. The case described is most likely that of Secondary Hyperparathyroidism. Parathyroid Adenoma is a cause of Primary Hyperparathyroidism, which generally has HIGH serum Calcium, HIGH PTH, and LOW serum Phosphate levels. Primary Causes of Secondary Hyperparathyroidism are: Chronic Kidney Disease (renal hyperparathyroidism), Gastrointestinal MALABSORPTION, Vitamin D deficiency, Liver Disease, or Chronic Lithium usage</p>\n<p><strong>Highyeild:</strong></p><p>Secondary hyperparathyroidism is primarily due to chronic kidney disease. It is associated with parathyroid hyperplasia. Diagnosis is made biochemically with low/normal calcium and high PTH. High phosphate and low vitamin D levels are seen.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: B. Secondary Hyperparathyroidism occurs primarily as a result of chronic kidney disease and is therefore referred to as renal hyperparathyroidism. Option: C. Intestinal Malabsorption can cause Secondary Hyperparathyroidism. Option: D. Vitamin D3 Deficiency can cause Secondary Hyperparathyroidism.</p>\n<p><strong>Extraedge:</strong></p><p>Renal transplantation is the main treatment, and medical management with replacements and binders is a bridge to transplantation. Calcimimetics reduce the need for surgery. Subtotal parathyroidectomy is the preferred surgery.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A known case of SECONDARY HYPERPARATHYROIDISM on medical management was taken up for surgery. All of the following can be an indication for this EXCEPT:", "options": [{"label": "A", "text": "Severely impaired quality of life due to either SHPT or intolerance to Calcimimetics.", "correct": false}, {"label": "B", "text": "PERSISTENT or RECURRENT disease, the origin of which cannot be elucidated.", "correct": true}, {"label": "C", "text": "When SHPT is refractory to vitamin D replacement or vitamin D analogs and prolonged survival is anticipated.", "correct": false}, {"label": "D", "text": "When sufficient reduction in parathyroid hormone cannot be achieved with the use of Calcimimetics.", "correct": false}], "correct_answer": "B. PERSISTENT or RECURRENT disease, the origin of which cannot be elucidated.", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>PERSISTENT or RECURRENT disease, the origin of which cannot be elucidated. In case of PERSISTENT or RECURRENT disease, the origin of which cannot be elucidated, surgical management should be avoided. PROPOSED INDICATIONS FOR SURGICAL MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM (SHPT) IN THE ERA OF CALCIMIMETICS. When SHPT is refractory to vitamin D replacement or vitamin D analogues and prolonged survival is anticipated. Severely impaired quality of life due to either SHPT or intolerance to Calcimimetics. When sufficient reduction in parathyroid hormone cannot be achieved with use of Calcimimetics. Thyroid surgery is also required (thyroid carcinoma)</p>\n<p><strong>Highyeild:</strong></p><p>Indications for surgical management The surgery is needed when SHPT is refractory to vitamin D replacement or analogs. Severe impairment of quality of life or intolerance to calcimimetics can also warrant surgery. Surgery is needed when calcimimetics cannot achieve sufficient reduction in PTH. Thyroid surgery is also required when there is thyroid carcinoma.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option A. Severely impaired quality of life due to either SHPT or intolerance to Calcimimetics is an indication for Surgery. Option C. Surgery is indicated when SHPT is refractory to vitamin D replacement or vitamin D analogs and prolonged survival is anticipated. Option D. Surgery is indicated when sufficient reduction in parathyroid hormone cannot be achieved with the use of Calcimimetics.</p>\n<p><strong>Extraedge:</strong></p><p>Surgical intervention leads to a dramatic response. Biochemical parameters improve immediately and can last up to 3 years post-surgery. Patients report subjective improvements in symptoms such as bone pain, pruritus, fatigue, and depression. Bone metabolism improves, with about a 10% increase in trabecular bone and immediate suppression of bone resorption and acceleration of new bone formation.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 50-year-old patient, who underwent a renal transplant for treatment of Secondary Hyperparathyroidism, was found to have persistent autonomous hypercalcemic hyperparathyroidism on follow-up. The following causes can all cause this to happen, EXCEPT:", "options": [{"label": "A", "text": "Non-suppressible PTH secretion.", "correct": false}, {"label": "B", "text": "Slow involution of enlarged Parathyroid Glands.", "correct": false}, {"label": "C", "text": "Increase Calcitriol Levels Post-Transplant.", "correct": true}, {"label": "D", "text": "Impaired graft function.", "correct": false}], "correct_answer": "C. Increase Calcitriol Levels Post-Transplant.", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Increase Calcitriol Levels Post-Transplant. The case describes is that of Tertiary Hyperparathyroidism. Tertiary hyperparathyroidism is a persistent autonomous hypercalcemic hyperparathyroidism occurring after kidney transplantation Insufficient calcitriol conversion by the transplanted kidney can Lead to Tertiary Hyperparathyroidism. Calcitriol increase causes PTH to drop & deficiency leads to Hyperparathyroidism. A number of proposed factors may prevent the Iinvolution of the hyperplastic parathyroid glands following treatment of the underlying renal impairment: These include: Impaired graft function, Non-suppressible PTH secretion, Slow involution of enlarged Parathyroid glands, or Insufficient calcitriol conversion by the transplanted kidney.</p>\n<p><strong>Highyeild:</strong></p><p>Tertiary hyperparathyroidism occurs after kidney transplantation Hyperplastic parathyroid glands may not involute after renal impairment resolution Factors include : impaired graft function, non-suppressible PTH secretion, slow involution, or insufcient calcitriol conversion Results in persistent autonomous hypercalcemia hyperparathyroidism</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Non-suppressible PTH secretion can lead to Tertiary Hyperparathyroidism Option: B. Slow involution of enlarged Parathyroid Glands can lead to Tertiary Hyperparathyroidism Option: D. Impaired graft function can lead to Tertiary Hyperparathyroidism</p>\n<p><strong>Extraedge:</strong></p><p>Calcimimetics in tertiary hyperparathyroidism are controversial and not approved. Surgery is the definitive management strategy. Subtotal or total parathyroidectomy with autotransplantation are acceptable options. Gland volume left approximately four times normal to minimize complications. Total parathyroidectomy without autograft is not an option due to persistent hypocalcemia.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 58-year-old man, who underwent a Renal Transplant for treatment of Secondary Hyperparathyroidism, was found to have elevated serum calcium, elevated PTH, and reduced PHOSPHATE on follow-up 1-year post renal transplantation. What is the next course of treatment that can be offered to the patient in case of the progression of symptoms?", "options": [{"label": "A", "text": "Total Parathyroidectomy without Autologous Transplant", "correct": false}, {"label": "B", "text": "Sub-Total Parathyroidectomy", "correct": true}, {"label": "C", "text": "Second Renal Transplant", "correct": false}, {"label": "D", "text": "Cinacalcet-based medical treatment.", "correct": false}], "correct_answer": "B. Sub-Total Parathyroidectomy", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Sub-Total Parathyroidectomy The biochemical diagnosis of Tertiary hyperparathyroidism is confirmed by an elevated total or ionized calcium, with an associated elevated or unsuppressed PTH and a reduced phosphate occurring at least 1-year post renal transplantation. The use of Calcimimetics in Tertiary Hyperparathyroidism remains controversial and has not been approved for this indication. The majority of endocrine surgeons will opt for a Subtotal Parathyroidectomy.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Total parathyroidectomy without an autograft is not a treatment option due to the postoperative and persistent difficulties in managing the associated hypocalcemia. Option: C . Second Renal Transplant is not an option required for treatment, as the Pathology is in Parathyroid Gland. Option: D . The use of Calcimimetics in Tertiary Hyperparathyroidism has not been approved.</p>\n<p><strong>Extraedge:</strong></p><p>Calcimimetics in tertiary hyperparathyroidism are controversial and not approved. Surgery is the definitive management strategy. Subtotal or total parathyroidectomy with autotransplantation are acceptable options. Gland volume left approximately four times normal to minimize complications. Total parathyroidectomy without autograft is not an option due to persistent hypocalcemia.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A known case of Hypertension, after surgery for Tertiary Hyperparathyroidism, started exhibiting the following sign. What part of the treatment can lead to this?", "options": [{"label": "A", "text": "Hypocalcemia due to Total Parathyroidectomy.", "correct": true}, {"label": "B", "text": "Hypercalcemia following surgery due to recurrence.", "correct": false}, {"label": "C", "text": "Hyperkalemia due to Blood Pressure Medications.", "correct": false}, {"label": "D", "text": "Hypophosphatemia following correction of disease.", "correct": false}], "correct_answer": "A. Hypocalcemia due to Total Parathyroidectomy.", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1683766898449-QTDS025007IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Hypocalcemia due to Total Parathyroidectomy. A complication after Total Parathyroidectomy is Hypocalcemia. Most patients with postoperative hypocalcemia can be treated with Oral Calcium and Vitamin D supplements. Physical examination in hypocalcemia reveals: POSITIVE Chvostekâ€™s sign, which is a contraction of facial muscles elicited by tapping on the facial nerve anterior to the ear. POSITIVE Trousseauâ€™s Sign (image below) is a carpopedal spasm that is elicited by occluding blood flow to the forearm with a blood pressure cuff for 2â€“3 minutes.</p>\n<p><strong>Highyeild:</strong></p><p>Cause of morbidity and mortality: Hypercalcaemia from PTH secretion. Treatment goal: Control hypercalcemia and remove carcinoma. Surgery is the main treatment for primary and locally recurrent diseases. Complete resection is important to prevent seeding and recurrence. En bloc resection, associated thyroid lobectomy, and central neck dissection are controversial.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Image shows Positive Chvostek